LEVEL OF STRESS IN ADOLESCENTS WITH FUNCTIONAL SOMATIC DISORDERS. CORRECTION METHODS

DOI: https://doi.org/10.29296/25877305-2023-01-16
Issue: 
1
Year: 
2023

Yu. Kostyuchenko(1); T. Potupchik(2), Candidate of Medical Sciences; L. Evert(1, 3), MD; O. Chudinova(3), Candidate of Biological Sciences
1-Federal Research Center «Krasnoyarsk Scientific Center of the Siberian Branch
of the Russian Academy of Sciences», Research Institute of Medical Problems
of the North
2-Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry
of Health of the Russia
3-N.F. Katanov Khakass State University, Ministry of Science and Higher Education of the Russia, Abakan

The article is devoted to the actual problem of modern medicine - the analysis of the association of functional somatic disorders (FSD) in adolescents with the presence and level of stress. A review of data on the prevalence, etiology and clinical manifestations of the main types of FSD (recurrent headaches and abdominal pain, dorsalgia, asthenic syndrome, syncope and panic attacks) in children and adolescents was carried out. The results of our own study are included, which showed that a high level of stress was associated with the presence of asthenic syndrome (AS), chronic tension headache (TH), and frequent abdominal pain. Moderately and significantly increased levels of stress were associated with the presence of arterial hypertension (AH), AS, frequent abdominal pain, frequent pain in the cervical spine (CS), and panic disorders in children. Approaches to the correction of the level of stress tension and the prevention of its negative impact on the development of FSD are highlighted. The need for further scientific research in this direction is emphasized.
Keywords: 
teenagers
stress tension
functional somatic disorders
recurrent pain syndromes
asthenic syndrome
syncope
panic disorders
arterial hypertension
phytopreparations
Nervo-Vit.

References: 
  1. Abolyan L.V., Berezantsev A.Yu. Psychosomatic health of children and adolescents as an interdisciplinary problem. Health is the basis of human potential: problems and ways to solve them. 2012; 7 (2): 652–3 (in Russ.).
  2. Akarachkova E.S., Vershinina S.V., Kotova O.V. et al. Bases of stress and its consequences therapy and prophylaxis in children and adolescents. Current Pediatrics. 2013; 12 (3): 38–44 (in Russ.). DOI: 10.15690/vsp.v12i3.679
  3. Anisimova S.Yu., Rachin A.P. Dorsopathy. Neurological Bulletin. 2012; 2: 21–4 (in Russ.).
  4. Askalonova S.B. To the question of the methods of correction of the conditions of stress. Vestnik of the Mari State University. 2015; 3 (18): 8–12 (in Russ.).
  5. Barnaulov O.D., Pospelova M.L. Phytotherapy in neurology. St. Petersburg: N-L., 2009 (in Russ.).
  6. Bokova E.C., Bereznyakov A.V. Is there a future for sedatives of plant origin? VIII International Student Scientific Conference. Student Scientific Forum – 2016 (in Russ.).
  7. Bryazgunov I.P. Psychosomatics in children. M.: Psychotherapy, 2009 (in Russ.).
  8. Vasilyeva L.V., Evert L.S., Tereshchenko S.Yu. et al. Borderline mental disorders in schoolchildren. S.S. Korsakov Journal of Neurology and Psychiatry. 2015; 115 (4): 16–9 (in Russ.). DOI: 10.17116/jnevro20151154116-19
  9. Vasilyeva L.V., Evert L.S., Tereshchenko S.Yu. et al. Panic disorders in schoolchildren of Siberia (on the example of Krasnoyarsk). Profilakticheskaya i klinicheskaya meditsina. 2014; 2 (51): 93–6 (in Russ.).
  10. Vitamins and minerals in modern clinical medicine. Possibilities of therapeutic and preventive technologies. Methodological recommendations. Ed. Gromovoy O.A., Namazovoy L.S. M., 2003 (in Russ.).
  11. Gorkov V.A., Rayushkin V.A., Oleychik I.V. et al. Phytotherapy of moderate depression with St. John's wort preparations (analytical review). Psychiatry and psychopharmacotherapy. 2000; 2 (6): 184–7 (in Russ.).
  12. State Register of Medicines (in Russ.). URL: https://grls.rosminzdrav.ru/
  13. Elistratov D., Grigoryev K. Phytotherapy in the treatment of depressive states in adolescents. Vrach. 2022; 33 (9): 32–5 (in Russ.). DOI: 10.29296/25877305-2022-09-05
  14. Zakharova I.N., Ershova I.B., Tvorogova T.M. et al. Stress in children and adolescent is a burning issue of today. Medical Council. 2021; 1: 237–46 (in Russ.). DOI: 10.21518/2079-701X-2021-1-237-246
  15. Zakharova I.N., Tvorogova T.M., Pshenichnikova I.I. Current guidelines for diagnosis and treatment of vegetative dystonia in children and adolescents. Medical Council. 2016; 16: 116–23 (in Russ.). DOI: 10.21518/2079-701X-2016-16-116-123
  16. Zakharova I.N., Tvorogova T.M., Pshenichnikova I.I. et al. Stress and stress-induced disorders in children. Medical Council. 2018; 11: 110–6 (in Russ.). DOI: 10.21518/2079-701X-2018-11-110-116
  17. Kalacheva A.G. Element-specific indicators of neurotropic functions of magnesium. M., 2011 (in Russ.).
  18. Kalinina M.A., Baz L.L. Psychosomatic disorders in children in pediatric hospital settings. The Scientific Notes of the Pavlov University. 2013; 20 (4): 84–6 (in Russ.). DOI: 10.24884/1607-4181-2013-20-4-84-86
  19. Kravtsova N.A., Katasonova A.V., Dovzhenko A.Yu. et al. Factors and mechanisms of psychosomatic disorders. Pacific Medical Journal. 2013; 4: 48–55 (in Russ.).
  20. Kukushkin A.V. The use of the phytopreparation "NERVO-VIT" in the treatment of patients with psychovegetative syndrome. Poliklinika. 2017; 1 (1): 29–32 (in Russ.).
  21. Lifintseva A.A., Kholmogorova A.B. Family factors of psychosomatic disorders in children and adolescents. Counseling Psychology and Psychotherapy. 2015; 23 (1): 70–83 (in Russ.).
  22. Lytkin V.A., Evert L.S. Vasovagal and orthostatic syncope in children and teenagers. Siberian Medical Review. 2011; 1 (67): 106–9 (in Russ.).
  23. Makarov I.V. Clinical psychiatry of childhood and adolescence. St. Petersburg: Science and Technology, 2013 (in Russ.).
  24. Pankov D., Neudakhin E.V., Moreno I.G. Somatoform disorders and vegetative-vascular dystonia in children and adolescents. M., 2019 (in Russ.).
  25. Potupchik T., Veselova O., Evert L. et al. A spectrum of pharmacological effects of glycine. Vrach. 2015; 12: 14–7 (in Russ.).
  26. Potupchik T., Evert L., Akhmeldinova Yu. Use of native type II collagen as part of the multiagent Gibelli Flex Active. Vrach. 2018; 29 (12): 33–7 (in Russ.). DOI: 10.29296/25877305-2018-12-08
  27. Ryaguzova A.V. Overview of major research into risk factors of psychosomatic disorders. Global scientific potential. 2013; 9 (30): 13–9 (in Russ.).
  28. Simakov A., Panina M., Chekulaeva L.I. et al. Eltacin® treatment in children with autonomic dysfunction. Vrach. 2015; 9: 21–4 (in Russ.).
  29. Storozhakov G.I., Shamrey V.K. Psychosomatic spectrum disorders. Pathogenesis, diagnosis, treatment: a guide for doctors. St. Petersburg: SpecLit, 2014 (in Russ.).
  30. Studenikin V.M., Balkanskaya S.V., Shelkovsky V.I. Restless children and the use of herbal preparations. Lechaschi Vrach. 2007; 8: 92–3 (in Rus.).
  31. Tereshchenko S.Yu., Evert L.S., Lytkin V.A. et al. Syncopal states in children and adolescents: issues of differential diagnosis. Consilium Medicum. Pediatrics. 2010; 2: 42–9 (in Russ.).
  32. Evert L.S., Borozdun S.V., Bobrova E.I. et al. Diagnosis of connective tissue dysplasia using biomarkers. Journal of the Siberian Federal University. Series: Chemistry. 2009; 2 (4): 385–90 (in Russ.).
  33. Evert L.S., Potupchik T.V., Zaitseva O.I. et al. Psychological adaptation of teenagers in contemporary educational environment. Rossiyskiy Pediatricheskiy Zhurnal. 2015; 18 (6): 16–9 (in Russ.).
  34. Balch P.A. Prescription for nutritional healing (A practical A-to-Z reference to drug-free remedies using vitamins, minerals, herbs & food supplements). 4th ed. New York: Avery. A member of Penguin Group (USA) Inc., 2006.
  35. De Lenardis M., Schindler R., Classen H.G. Hypomagnesemia and suboptimal plasma-Mg levels in diabetes mellitus: frequencies and consequences. Magnesium-bulletin. 2000; 22 (3): 53–9.
  36. Goodman R.G., Slobodskaya H.R., Knyazev G.G. Russian child mental health: a cross-sectional study of prevalence and risk factors. Eur Child Adolesc Psychiatry. 2005; 14: 28–33. DOI: 10.1007/s00787-005-0420-8
  37. Hanni A. Magnesium and the insulin resistance syndrome. Acta Universitatis Upsaliensis, 2001.
  38. Linde K., Berner M.M., Kriston L. St John’s wort for major depression. Cochrane Database Syst Rev. 2008; 2008 (4): CD000448. DOI: 10.1002/14651858
  39. Shikov A., Pozharitskaya O., Makarov V. et al. Effect of Leonurus cardiac oil extract in patients with arterial hypertension accompanied by anxiety and sleep disorders. Phytother Res. 2011; 25 (4): 540–3. DOI: 10.1002/ptr.3292
  40. Song X., Wang T., Zhang Z. et al. Leonurine exerts anti-inflammatory effect by regulating inflammatory signaling pathways and cytokines in LPS-induced mouse mastitis. Inflammation. 2015; 38 (1): 79–88. DOI: 10.1007/s10753-014-0009-9
  41. Torshin I.Yu., Gromova O.A. Magnesium and pyridoxine: fundamental studies and clinical practice New York: Nova Science Publishers, 2009.
  42. Walker A.F., Marakis G., Christie S. et al. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003; 16 (3): 183–91.
  43. Wojtyniak K., Szymanski M., Matlawska I. Leonurus cardiaca L. (Motherwort): A Review of its Phytochemistry and Pharmacology. Phytother Res. 2013; 27 (8): 1115–20. DOI: 10.1002/ptr.4850